Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Activity of Cabozantinib After Immune Checkpoint Blockade in Metastatic Clear-Cell Renal Cell CarcinomaEur. J. Cancer 2020 Aug 01;135(xx)203-210, BA McGregor, A-K A Lalani, W Xie, et al
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.